Safety of Remimazolam in Vulnerable Populations [Corrigendum]
Year: 2025
Type: erratum
Abstract: Ge JY, Deng BR, Cao XH, Liu XJ. Drug Des Devel Ther. 2025;19:8691–8709. Page 8698, Kidney Disease, second paragraph, line 4, the text “remifentanil group” should read “remimazolam group”. The authors apologize for this error.
Authors: Ge JY, Deng BR, Cao XH, Liu XJ
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7102431729
Cites:
Cited by:
Related to:
